Skip to main content
TipRanks
Go Ultimate75% OFF

Celon Pharma SA (8RP) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Celon Pharma SA has a market cap or net worth of EUR 195.55M. The enterprise value is EUR 1.07B.

Market Cap
EUR 195.55M
Enterprise Value
EUR 1.07B

Share Statistics

Celon Pharma SA has 53,911,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
53,911,500
Owned by Insiders
―
Owned by Institutions
0.22%

Financial Efficiency

Celon Pharma SA’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -14.09%.

Return on Equity (ROE)
-0.22
Return on Assets (ROA)
-0.17
Return on Invested Capital (ROIC)
-14.09%
Return on Capital Employed (ROCE)
-0.14
Revenue Per Employee
374.64K
Profits Per Employee
-141.72K
Employee Count
560
Asset Turnover
0.46
Inventory Turnover
9.55

Valuation Ratios

The current PE Ratio of Celon Pharma SA is 7.61. Celon Pharma SA’s PEG ratio is 0.17.

PE Ratio
7.61
PS Ratio
3.97
PB Ratio
1.73
Price to FCF
-15.21
Price to Operating Cash Flow
31.57
PEG Ratio
0.17

Income Statement

In the last 12 months, Celon Pharma SA had revenue of 209.80M and earned -79.36M in profits. Earnings per share was -1.47.

Revenue
209.80M
Gross Profit
-39.48M
Operating Income
-56.76M
Pretax Income
-58.97M
Net Income
-79.36M
EBITDA
-10.48M
Earnings Per Share (EPS)
-1.47

Cash Flow

In the last 12 months, operating cash flow was 27.29M and capital expenditures -83.92M, giving a free cash flow of -56.63M billion.

Operating Cash Flow
27.29M
Free Cash Flow
-56.63M
Free Cash Flow per Share
-1.05

Dividends & Yields

Celon Pharma SA pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-6.57%
Earnings Yield
12.86%

Stock Price Statistics

Beta
0.30
52-Week Price Change
-29.13%
50-Day Moving Average
4.22
200-Day Moving Average
4.65
Relative Strength Index (RSI)
27.68
Average Volume (3m)
57

Important Dates

Celon Pharma SA upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).

Last Earnings Date
Sep 16, 2026
Next Earnings Date
Nov 18, 2026
Ex-Dividend Date
―

Financial Position

Celon Pharma SA as a current ratio of 1.62, with Debt / Equity ratio of 5.21%

Current Ratio
1.62
Quick Ratio
1.20
Debt to Market Cap
0.00
Net Debt to EBITDA
0.04
Interest Coverage Ratio
-35.54

Taxes

In the past 12 months, Celon Pharma SA has paid 20.40M in taxes.

Income Tax
20.40M
Effective Tax Rate
-0.35

Enterprise Valuation

Celon Pharma SA EV to EBITDA ratio is 115.85, with an EV/FCF ratio of -16.89.

EV to Sales
4.41
EV to EBITDA
115.85
EV to Free Cash Flow
-16.89
EV to Operating Cash Flow
35.04

Balance Sheet

Celon Pharma SA has EUR 34.53M in cash and marketable securities with EUR 128.44M in debt, giving a net cash position of -EUR 93.91M billion.

Cash & Marketable Securities
EUR 34.53M
Total Debt
EUR 128.44M
Net Cash
-EUR 93.91M
Net Cash Per Share
-EUR 1.74
Tangible Book Value Per Share
EUR 8.78

Margins

Gross margin is 6.76%, with operating margin of -11.78%, and net profit margin of 51.08%.

Gross Margin
6.76%
Operating Margin
-11.78%
Pretax Margin
66.23%
Net Profit Margin
51.08%
EBITDA Margin
3.81%
EBIT Margin
-16.05%